Automated description from the Alliance of Genome Resources (Release 3.2)
Predicted to have inositol 1,3,4,5 tetrakisphosphate binding activity and phosphatidylinositol binding activity. Predicted to be involved in inositol lipid-mediated signaling. Predicted to localize to mitochondrial envelope and plasma membrane. Is expressed in several structures, including brain; future brain; heart; inner ear; and limb bud. Orthologous to human ADAP2 (ArfGAP with dual PH domains 2).